We are one of the largest global pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical and biotech manufacturers improve patient access to products and enhance patient care. We deliver innovative programs and services designed to increase the effectiveness and efficiency of the pharmaceutical supply chain in both human and animal health. Our operations are organized based upon the products and services we provide to our customers, which include a comprehensive offering of brand-name, specialty brand-name, and generic pharmaceuticals, over-the-counter healthcare products, and related services. The acquisition of Alliance Healthcare expands our reach and solutions in pharmaceutical distribution and adds to our depth and breadth of global manufacturer services, which is essential for maintaining operational continuity and adapting to external pressures. We have undertaken a strategic evaluation of our reporting structure to reflect our expanded international presence, which enhances our organizational effectiveness and resilience in the face of market volatility and competitive landscapes. Our revenue growth is influenced by various factors, including industry growth trends, the introduction of innovative therapies, and the impact of the COVID-19 pandemic, which necessitates a focus on business continuity and adaptability. The increase in gross profit and operating income demonstrates our ability to maintain performance under pressure, while our strategic initiatives, including the extension of distribution agreements, are designed to create incremental growth and efficiencies. We recognize the importance of risk management and resource allocation in navigating complex situations and ensuring organizational health. The integration of Alliance Healthcare is expected to enhance our operational flexibility and resilience strategies, allowing us to respond effectively to environmental disruptions. Our commitment to continuous improvement and innovation is reflected in our capital expenditures, which support technology initiatives and facility expansions aimed at enhancing operational management and strategic adaptation. We anticipate that our future revenue growth will be supported by our ability to foresee and confront challenges, including changes in customer needs and market dynamics. The management of our cash flows and working capital performance is critical for sustaining our operations and funding future growth opportunities. We are also focused on maintaining strong relationships with stakeholders and fostering collaboration networks to enhance our organizational interconnectedness and resilience. The ongoing evaluation of our financial position and strategic planning is essential for addressing uncertainties and ensuring our long-term success in a turbulent market environment.